Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 23 04:00PM ET
Dollar change
Percentage change
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-8.33% Shs Outstand Perf Week-2.06%
SponsorWisdom Tree ETF Type Tagsequity Return% 3Y-12.56% Total Holdings100 Perf Month5.99%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM2.50M Perf Quarter10.31%
IndexWisdomTree BioRevolution Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y5.45%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-7.90%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range13.37 - 18.47 Perf YTD0.04%
Dividend TTM0.14 (0.80%) ESG Type Tags- Flows% 3M0.00% 52W High-8.66% Beta1.05
Dividend Ex-DateDec 22, 2023 Dividend Type Sector/Theme Flows% YTD-6.26% 52W Low26.15% ATR (14)0.24
Expense0.45% Structure Type Region Flows% 1Y RSI (14)60.60 Volatility1.31% 0.82%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.21 Prev Close16.66
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.89K Price16.87
SMA204.43% SMA504.46% SMA2005.73% Trades Volume187 Change1.28%
WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index ("index"). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.